{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:19:06Z","timestamp":1784204346821,"version":"3.55.0"},"reference-count":132,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Long Covid Web","award":["Seed Funding"],"award-info":[{"award-number":["Seed Funding"]}]},{"name":"Fonds Recherche Qu\u00e9bec Sant\u00e9"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Drug Safety"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>The COVID-19 pandemic has renewed attention to complex chronic health conditions that challenge conventional biomedical paradigms. Syndromes such as postural orthostatic tachycardia syndrome and myalgic encephalomyelitis\/chronic fatigue syndrome have gained broader visibility through the lens of Long COVID. As global vaccination campaigns expanded, a subset of individuals began reporting similarly persistent, multisystem symptoms following COVID-19 immunization\u2014informally referred to as post-COVID-19 vaccination syndrome. These presentations, which include dysautonomia, neuropathic pain, post-exertional malaise, and cognitive dysfunction, resemble post-infectious syndromes and may involve shared immune-related mechanisms. Although no causal relationship to vaccination has been established, these cases\u2014together with comparable reports following other vaccines\u2014highlight limitations in current vaccine safety systems for detecting and evaluating complex chronic outcomes. This article introduces the concept of complex chronic adverse events following immunization (CC-AEFIs) as a pragmatic, surveillance-oriented framework to support the systematic identification and investigation of such cases. CC-AEFIs are not syndromic diagnoses but a higher-order category encompassing persistent, multifactorial conditions that may follow immunization yet challenge existing pharmacovigilance definitions and tools. These conditions often involve multiple organ systems, delayed onset, fluctuating trajectories, diagnostic ambiguity, and symptom heterogeneity. Drawing on the author\u2019s lived experience as an affected patient and integrating clinical, regulatory, and experiential evidence, the analysis examines structural and epistemic limitations across the pharmacovigilance continuum\u2014from underrecognition in clinical settings to analytic exclusion and constrained governance. It concludes by proposing reforms to strengthen safety-system responsiveness, including enhanced diagnostic training, longitudinal surveillance, patient-reported outcome integration, and analytic transparency. Addressing these limitations is essential to sustain public trust, ensure equitable care, and uphold the scientific integrity of immunization programs.<\/jats:p>","DOI":"10.1177\/20420986251395925","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:45:28Z","timestamp":1766565928000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Complex chronic adverse events following immunization: a systemic critique and reform proposal for vaccine pharmacovigilance"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9688-6149","authenticated-orcid":false,"given":"Tiff-Annie","family":"Kenny","sequence":"first","affiliation":[{"name":"Facult\u00e9 de m\u00e9decine, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, QC, Canada"},{"name":"CRCHU de Qu\u00e9bec Universit\u00e9 Laval, Quebec, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/medethics-2016-103691"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1525\/maq.1992.6.4.02a00030"},{"key":"e_1_3_4_4_2","article-title":"How should clinicians minimize harms and maximize benefits when diagnosing and treating disorders without biomarkers?","volume":"23","author":"Tolchin B","year":"2021","unstructured":"Tolchin B, Tolchin DW, Stein MA. How should clinicians minimize harms and maximize benefits when diagnosing and treating disorders without biomarkers? AMA J Ethics 2021; 23: E530\u2013E536.","journal-title":"AMA J Ethics"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fsoc.2024.1283695"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12144-024-06935-0"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113426"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.860198"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57050418"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.ada0394"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.adj5565"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01810-6"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado2101"},{"key":"e_1_3_4_14_2","article-title":"Patients as knowledge partners in the context of complex chronic conditions","volume":"51","author":"Hsu VJ","year":"2024","unstructured":"Hsu VJ, Moodie M, Dumes AA, et al Patients as knowledge partners in the context of complex chronic conditions. M\u00e9d Humanit 2024; 51: e012957.","journal-title":"M\u00e9d Humanit"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-022-00177-8"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.70070"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111642"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154497"},{"key":"e_1_3_4_19_2","article-title":"Post-vaccination syndrome: a descriptive analysis of reported symptoms and patient experiences after Covid-19 immunization","author":"Krumholz HM","year":"2023","unstructured":"Krumholz HM, Wu Y, Sawano M, et al Post-vaccination syndrome: a descriptive analysis of reported symptoms and patient experiences after Covid-19 immunization. medRxiv, 2023.","journal-title":"medRxiv"},{"key":"e_1_3_4_20_2","article-title":"Immunization-related complex regional pain syndrome: a systematic review of case reports","volume":"3","author":"Copenhaver WK","year":"2024","unstructured":"Copenhaver WK, Goodwin BJ, Simonetti A, et al Immunization-related complex regional pain syndrome: a systematic review of case reports. PCN Rep 2024; 3: e70041.","journal-title":"PCN Rep"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/clinpract13060139"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.992686"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e43478"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12121378"},{"key":"e_1_3_4_25_2","author":"Paul-Ehrlich-Institut","year":"2023","unstructured":"Paul-Ehrlich-Institut. Statement from the Paul-Ehrlich-Institut on \u201cpost-vac syndrome\u201d after COVID-19 vaccination. Paul-Ehrlich-Institut, Germany, 2023.","journal-title":"Statement from the Paul-Ehrlich-Institut on \u201cpost-vac syndrome\u201d after COVID-19 vaccination"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12070790"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vacune.2024.02.010"},{"key":"e_1_3_4_28_2","first-page":"506","article-title":"A retrospective analysis of clinically confirmed long post-COVID vaccination syndrome","volume":"8","author":"Finterer J","year":"2022","unstructured":"Finterer J, Scorza FA. A retrospective analysis of clinically confirmed long post-COVID vaccination syndrome. J Clin Transl Res 2022; 8: 506\u2013508.","journal-title":"J Clin Transl Res"},{"key":"e_1_3_4_29_2","article-title":"A case report: long post-COVID vaccination syndrome during the eleven months after the third moderna dose","volume":"14","author":"Finsterer J.","year":"2022","unstructured":"Finsterer J. A case report: long post-COVID vaccination syndrome during the eleven months after the third moderna dose. Cureus 2022; 14: e32433.","journal-title":"Cureus"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04335-0"},{"key":"e_1_3_4_31_2","article-title":"Comparative analysis of Long COVID and post-vaccination syndrome: a cross-sectional study of clinical symptoms and machine learning-based differentiation","author":"Krumholz HM","year":"2025","unstructured":"Krumholz HM, Sawano M, Wu Y, et al Comparative analysis of Long COVID and post-vaccination syndrome: a cross-sectional study of clinical symptoms and machine learning-based differentiation. medRxiv, 2025.","journal-title":"medRxiv"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2494934"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2025.111711"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2969-z"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3070-3"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102603"},{"key":"e_1_3_4_37_2","first-page":"211","article-title":"HPV vaccination syndrome: a clinical mirage, or a new tragic fibromyalgia model","volume":"14","author":"Mart\u00ednez-Lav\u00edn M.","year":"2017","unstructured":"Mart\u00ednez-Lav\u00edn M. HPV vaccination syndrome: a clinical mirage, or a new tragic fibromyalgia model. Reumatol Clin 2017; 14: 211\u2013214.","journal-title":"Reumatol Clin"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-9036-1"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.098"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0593-3"},{"key":"e_1_3_4_41_2","volume-title":"Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification","author":"WHO","year":"2019","unstructured":"WHO. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification. 2nd ed. World Health Organization, 2019.","edition":"2"},{"key":"e_1_3_4_42_2","article-title":"Modernising vaccine surveillance systems to improve detection of rare or poorly defined adverse events","volume":"365","author":"Chandler RE.","year":"2019","unstructured":"Chandler RE. Modernising vaccine surveillance systems to improve detection of rare or poorly defined adverse events. BMJ 2019; 365: l2268.","journal-title":"BMJ"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2402379"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.02.088"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00850-X"},{"key":"e_1_3_4_46_2","unstructured":"WHO. Vaccines and immunization https:\/\/www.who.int\/health-topics\/vaccines-and-immunization#tab=tab_1 (accessed 4 August 2025)."},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-022-01431-6"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-18342-y"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41256-022-00255-1"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060807"},{"key":"e_1_3_4_51_2","article-title":"Living with vaccine-induced immune thrombocytopenia and thrombosis: a qualitative study","volume":"13","author":"Bennett P","year":"2023","unstructured":"Bennett P, Celik F, Winstanley J, et al Living with vaccine-induced immune thrombocytopenia and thrombosis: a qualitative study. BMJ Open 2023; 13: e072658.","journal-title":"BMJ Open"},{"key":"e_1_3_4_52_2","article-title":"Qualitative study of the consequences of vaccine-induced immune thrombocytopenia and thrombosis: the experiences of family members","volume":"13","author":"Bennett P","year":"2023","unstructured":"Bennett P, Celik F, Winstanley J, et al Qualitative study of the consequences of vaccine-induced immune thrombocytopenia and thrombosis: the experiences of family members. BMJ Open 2023; 13: e080363.","journal-title":"BMJ Open"},{"key":"e_1_3_4_53_2","article-title":"Well-being of women referred due to suspected side effects after human papilloma virus vaccination","volume":"67","author":"Kjaer J","year":"2020","unstructured":"Kjaer J, Jensen TS, Rolving N, et al Well-being of women referred due to suspected side effects after human papilloma virus vaccination. Dan M\u00e9d J 2020; 67: A12190735.","journal-title":"Dan M\u00e9d J"},{"key":"e_1_3_4_54_2","first-page":"73","article-title":"Embodiment and the search for illness legitimacy among women with contested illnesses","volume":"19","author":"Swoboda DA.","year":"2006","unstructured":"Swoboda DA. Embodiment and the search for illness legitimacy among women with contested illnesses. Mich Feminist Stud 2006; 19: 73\u201390.","journal-title":"Mich Feminist Stud"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674370404901003"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph22020275"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225060-00012"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.07.003"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14080799"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1490744"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102921"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-985332"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102808"},{"key":"e_1_3_4_64_2","volume-title":"The hermeneutics of medicine and the phenomenology of health","author":"Svenaeus F.","year":"2023","unstructured":"Svenaeus F. The hermeneutics of medicine and the phenomenology of health. Springer International Publishing, 2023."},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/jmp\/jhz013"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1800.2003.00178.x"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.26913\/avant.2018.02.07"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2021.114326"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-025-09661-2"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11126-019-09704-6"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmqr.2022.100167"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2025.108665"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1177\/1049732319888478"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1177\/10497323231188639"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1177\/1363459319857457"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.081239"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07609-y"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-017-4289-2"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2025.02.137"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2024.06.022"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(96)00325-X"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2008.01211.x"},{"key":"e_1_3_4_83_2","volume-title":"Diagnostic controversy cultural perspectives on competing knowledge in healthcare","author":"Sachs L.","year":"2015","unstructured":"Sachs L. Making sense of unmeasurable suffering: the recontextualization of debut stories to a diagnosis of chronic fatigue syndrome. In: Smith-Morris C (ed.) Diagnostic controversy cultural perspectives on competing knowledge in healthcare. New York: Routledge, 2015."},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1177\/17423953211054032"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.17052"},{"key":"e_1_3_4_86_2","volume-title":"From global discourses to local realities: girls and young women\u2019s experiences of harm post Human Papillomavirus vaccination, El Carmen de Bol\u00edvar, Colombia","author":"Arevalo NL.","year":"2023","unstructured":"Arevalo NL. From global discourses to local realities: girls and young women\u2019s experiences of harm post Human Papillomavirus vaccination, El Carmen de Bol\u00edvar, Colombia. Rotterdam, Netherlands: Erasmus University, 2023."},{"key":"e_1_3_4_87_2","doi-asserted-by":"crossref","unstructured":"Baltar-Moreno A Puello-Sarabia C Carrazco-Delgado BF. Revisi\u00f3n narrativa del caso de la vacuna contra el VPH en El Carmen de Bol\u00edvar Colombia (2014\u20132021). Gerencia y Pol\u00edticas Salud 2022; 21. https:\/\/revistas.javeriana.edu.co\/index.php\/gerepolsal\/article\/view\/34614","DOI":"10.11144\/Javeriana.rgps21.rncv"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1511667"},{"key":"e_1_3_4_89_2","article-title":"Covid-19 vaccine trial protocols released","volume":"371","author":"Doshi P.","year":"2020","unstructured":"Doshi P. Covid-19 vaccine trial protocols released. BMJ 2020; 371: m4058.","journal-title":"BMJ"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629050-00003"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528090-00007"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-023-01302-7"},{"key":"e_1_3_4_93_2","author":"Tadrous M.","year":"2010","unstructured":"Tadrous M. Assessing the sensitivity of the Canadian adverse event following immunization surveillance system (CAEFISS). Theses and Dissertations (ETD) Paper 262, 2010.","journal-title":"Assessing the sensitivity of the Canadian adverse event following immunization surveillance system (CAEFISS)"},{"key":"e_1_3_4_94_2","author":"Lazarus R","year":"2010","unstructured":"Lazarus R, Klompas M, Bernstein S. Electronic Support for Public Health\u2013Vaccine Adverse Event Reporting System (ESP:VAERS). Grant Final Report Grant ID: R18 HS 017045, 2010.","journal-title":"Electronic Support for Public Health\u2013Vaccine Adverse Event Reporting System (ESP:VAERS)"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.072"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2083865"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-022-03326-x"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0001658"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0331093"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-12139-w"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2013.09.005"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.10.004"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12895"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52710"},{"key":"e_1_3_4_105_2","volume-title":"Beyond myalgic encephalomyelitis\/chronic fatigue syndrome: redefining an illness","author":"Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome; Board on the Health of Select Populations; and Institute of Medicine","year":"2015","unstructured":"Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome; Board on the Health of Select Populations; and Institute of Medicine. Beyond myalgic encephalomyelitis\/chronic fatigue syndrome: redefining an illness. Washington, DC: National Academies Press, 2015."},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2039017"},{"key":"e_1_3_4_107_2","article-title":"Assessment of long-term adverse events regarding different COVID-19 vaccine regimens within an 18-month follow-up study","volume":"81","author":"Larijani MS","year":"2023","unstructured":"Larijani MS, Sorouri R, Eybpoosh S, et al Assessment of long-term adverse events regarding different COVID-19 vaccine regimens within an 18-month follow-up study. Pathog Dis 2023; 81: ftad010.","journal-title":"Pathog Dis"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15625"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.p2582"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1192121"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.761643"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.03.029"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0931-5"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02269-0"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13947"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2021.01.009"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.19102\/icrm.2020.111102"},{"key":"e_1_3_4_118_2","first-page":"59","article-title":"COVID-19 symptoms over time: comparing long-haulers to ME\/CFS","volume":"9","author":"Jason LA","year":"2021","unstructured":"Jason LA, Islam MF, Conroy K, et al COVID-19 symptoms over time: comparing long-haulers to ME\/CFS. Fatigue 2021; 9: 59\u201368.","journal-title":"Fatigue"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.039"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0202-9"},{"key":"e_1_3_4_121_2","first-page":"30","article-title":"Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction: a review of the regulatory evidence from the European Medicines Agency","volume":"2","author":"Jefferson T","year":"2017","unstructured":"Jefferson T, J\u00f8rgensen L. Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction: a review of the regulatory evidence from the European Medicines Agency. Indian J M\u00e9d Ethics 2017; 2: 30\u201337.","journal-title":"Indian J M\u00e9d Ethics"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2020-111470"},{"key":"e_1_3_4_123_2","article-title":"Will Covid-19 vaccines save lives? Current trials aren\u2019t designed to tell us","volume":"371","author":"Doshi P.","year":"2020","unstructured":"Doshi P. Will Covid-19 vaccines save lives? Current trials aren\u2019t designed to tell us. BMJ 2020; 371: m4037.","journal-title":"BMJ"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812173392501"},{"key":"e_1_3_4_125_2","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0b013e3181ace703"},{"key":"e_1_3_4_126_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-36530-0_1"},{"key":"e_1_3_4_127_2","doi-asserted-by":"publisher","DOI":"10.3402\/meo.v15i0.4846"},{"key":"e_1_3_4_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100273"},{"key":"e_1_3_4_129_2","unstructured":"Brinth L. Responsum to assessment report on HPV-vaccines released by EMA November 26th 2015 https:\/\/www.ft.dk\/samling\/20151\/almdel\/suu\/bilag\/109\/1581470.pdf (2015 accessed 11 August 2025)."},{"key":"e_1_3_4_130_2","article-title":"Suspected side effects to the quadrivalent human papilloma vaccine","volume":"62","author":"Brinth L","year":"2015","unstructured":"Brinth L, Theibel AC, Pors K, et al Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J 2015; 62: A5064.","journal-title":"Dan Med J"},{"key":"e_1_3_4_131_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1519163"},{"key":"e_1_3_4_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126196"},{"key":"e_1_3_4_133_2","doi-asserted-by":"publisher","DOI":"10.4103\/2229-3485.86879"}],"container-title":["Therapeutic Advances in Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420986251395925","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20420986251395925","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20420986251395925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:41:10Z","timestamp":1777592470000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20420986251395925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":132,"alternative-id":["10.1177\/20420986251395925"],"URL":"https:\/\/doi.org\/10.1177\/20420986251395925","relation":{},"ISSN":["2042-0986","2042-0994"],"issn-type":[{"value":"2042-0986","type":"print"},{"value":"2042-0994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"article-number":"20420986251395925"}}